[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Embolotherapy Market

September 2021 | 98 pages | ID: GE5AB1219B92EN
BCC Research

US$ 2,750.00 US$ 5,500.00 -50 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SCOPE:

This report will focus on both embolic agents and support devices. These embolization devices are used across various indications such as in oncology, nephrology, neurology, urology and vascular diseases. The report also portrays the trends and dynamics affecting the market. The report also covers market projections to 2026, and it features company profiles. By geography, the market has been segmented into the following regions: North America, Europe, Asia-Pacific and Rest of the World. For market estimates, data has been provided for 2019 as the historic year, 2020 as the base year and 2021 as the estimation year; and market forecasts have been given for 2026.

REPORT INCLUDES:
  • 31 data tables and 16 additional tables
  • An overview of the global embolotherapy market with focus on both embolic agents and support devices
  • Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021, with projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the market potential for embolotherapy, by type, indication, procedure, end user, and region
  • Detailed description of types, history, benefits, and risks associated with embolization and coverage of relationship between minimally invasive procedures and embolotherapy
  • Identification of market drivers, restraints and other forces impacting the market and analysis of the regulatory framework and product recalls of the industry
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including Boston Scientific Corp., Johnson & Johnson, Medtronic Plc., Penumbra, Stryker Corp. and Terumo Corp.
CHAPTER 1 INTRODUCTION

Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Primary Research
Secondary Research
Research Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

CHAPTER 3 OVERVIEW OF EMBOLOTHERAPY

Overview
Types of Embolic Agents
Permanent Agents
Temporary Agents
History of Embolotherapy
Benefits of Embolization
Risks of Embolization

CHAPTER 4 MARKET DYNAMICS

Market Drivers
Increasing Demand for Minimally Invasive Procedures
Technological Advancements
Increasing Prevalence of Target Indications
Market Restraints
Lack of Skilled Interventional Radiologists
Complications Associated with Embolotherapy
Lack of Awareness
Market Recalls

CHAPTER 5 MARKET BREAKDOWN BY PRODUCT TYPE

Overview
Market Analysis
Global Market for Embolotherapy by Product Type
Global Market Shares of Embolotherapy by Product Type

CHAPTER 6 MARKET BREAKDOWN BY INDICATION

Overview
Market Analysis
Global Market Shares of Embolotherapy by Indication

CHAPTER 7 MARKET BREAKDOWN BY PROCEDURE

Overview
Market Analysis
Global Market Shares of Embolotherapy by Procedure Type

CHAPTER 8 MARKET BREAKDOWN BY END-USER

Overview
Market Analysis
Global Market Shares of Embolotherapy by End User Type

CHAPTER 9 MARKET BREAKDOWN BY REGION

Overview
Global Market for Embolotherapy by Region
North American Market for Embolotherapy
North American Market for Embolotherapy by Product Type
North American Market for Embolotherapy by Indication
North American Market for Embolotherapy by Procedure Type
North American Market for Embolotherapy by End User
European Market for Embolotherapy
European Market for Embolotherapy by Product Type
European Market for Embolotherapy by Indication
European Market for Embolotherapy by Procedure Type
European Market for Embolotherapy by End User
Asia-Pacific (APAC) Market for Embolotherapy
APAC Market for Embolotherapy by Product Type
APAC Market for Embolotherapy by Indication
APAC Market for Embolotherapy by Procedure Type
APAC Market for Embolotherapy by End User
Rest of the World (RoW) Market for Embolotherapy
RoW Market for Embolotherapy by Product Type
RoW Market for Embolotherapy by Indication
RoW Market for Embolotherapy by Procedure Type
RoW Market for Embolotherapy by End User

CHAPTER 10 COMPETITIVE LANDSCAPE

Mergers and Acquisitions
Key Developments
Global Company Share Analysis
Impact of COVID-19 on the Embolotherapy Market

CHAPTER 11 COMPANY PROFILES

ACANDIS GMBH
ABK BIOMEDICAL
BALT USA LLC
BOSTON SCIENTIFIC CORP.
COOK MEDICAL
GUERBET
JOHNSON & JOHNSON
KANEKA CORP.
MEDTRONIC PLC
MERIT MEDICAL SYSTEMS INC.
PENUMBRA INC.
SIRTEX MEDICAL INC.
STRYKER CORP.
TERUMO CORP.

LIST OF TABLES

Summary Table A: Global Market for Embolotherapy, Through 2026
Summary Table B: Global Market for Embolotherapy, by Region, Through 2026
Table 1: Embolization Device Recalled by FDA, 2019 and 2020
Table 2: Global Market for Embolotherapy, Through 2026
Table 3: Global Market for Embolotherapy, by Product Type, Through 2026
Table 4: Global Market for Embolotherapy, by Indication, Through 2026
Table 5: Global Market for Embolotherapy, by Procedure Type, Through 2026
Table 6: Global Market for Embolotherapy, by End User, Through 2026
Table 7: Global Market for Embolotherapy, by Region, Through 2026
Table 8: North American Market for Embolotherapy, by Product Type, Through 2026
Table 9: North American Market for Embolotherapy, by Indication, Through 2026
Table 10: North American Market for Embolotherapy, by Procedure Type, Through 2026
Table 11: North American Market for Embolotherapy, by End User, Through 2026
Table 12: European Market for Embolotherapy, by Product Type, Through 2026
Table 13: European Market for Embolotherapy, by Indication, Through 2026
Table 14: European Market for Embolotherapy, by Procedure Type, Through 2026
Table 15: European Market for Embolotherapy, by End User, Through 2026
Table 16: APAC Market for Embolotherapy, by Product Type, Through 2026
Table 17: APAC Market for Embolotherapy, by Indication, Through 2026
Table 18: APAC Market for Embolotherapy, by Procedure Type, Through 2026
Table 19: APAC Market for Embolotherapy, by End User, Through 2026
Table 20: RoW Market for Embolotherapy, by Product Type, Through 2026
Table 21: RoW Market for Embolotherapy, by Indication, Through 2026
Table 22: RoW Market for Embolotherapy, by Procedure Type, Through 2026
Table 23: RoW Market for Embolotherapy, by End User, Through 2026
Table 24: Boston Scientific Corp.: Business Segments
Table 25: Boston Scientific Corp.: Product Portfolio
Table 26: Boston Scientific Corp.: Financial Performance, 2016-2020
Table 27: Cook Medical: Business Segments
Table 28: Cook Medical: Product Portfolio
Table 29: Johnson & Johnson: Business Segments
Table 30: Johnson & Johnson: Product Portfolio
Table 31: Johnson & Johnson: Financial Performance, 2018-2020
Table 32: Medtronic Plc: Business Segments
Table 33: Medtronic Plc: Product Portfolio
Table 34: Medtronic Plc: Financial Performance, 2018-2020
Table 35: Merit Medical Systems Inc.: Business Segments
Table 36: Merit Medical Systems Inc.: Product Portfolio
Table 37: Merit Medical Systems Inc.: Financial Performance, 2016-2020
Table 38: Penumbra Inc: Business Segments
Table 39: Penumbra Inc.: Product Portfolio
Table 40: Penumbra: Financial Performance, 2018-2020
Table 41: Stryker Corp.: Business Segments
Table 42: Stryker Corp.: Product Portfolio
Table 43: Stryker Corp.: Financial Performance, 2016-2020
Table 44: Terumo Corp.: Business Segments
Table 45: Terumo Corp.: Financial Performance, 2015-2019

LIST OF FIGURES

Summary Figure A: Global Market for Embolotherapy, 2019-2026
Summary Figure B: Global Market for Embolotherapy, 2019-2026
Figure 1: Types of Embolic Agents
Figure 2: Global Market for Embolotherapy, 2019-2026
Figure 3: Global Market for Embolotherapy, by Product Type, 2019-2026
Figure 4: Global Market Shares of Embolotherapy, by Product Type, 2020
Figure 5: Global Market for Embolotherapy, by Indication, 2019-2026
Figure 6: Global Market Shares of Embolotherapy, by Indication, 2020
Figure 7: Global Market for Embolotherapy, by Procedure Type, 2019-2026
Figure 8: Global Market Shares of Embolotherapy, by Procedure Type, 2020
Figure 9: Global Market for Embolotherapy, by End User, 2019-2026
Figure 10: Global Market Shares of Embolotherapy, by End User, 2020
Figure 11: Global Market for Embolotherapy, by Region, 2019-2026
Figure 12: Global Market Shares of Embolotherapy, by Region, 2020
Figure 13: North American Market for Embolotherapy, by Product Type, 2019-2026
Figure 14: North American Market for Embolotherapy, by Indication, 2019-2026
Figure 15: North American Market for Embolotherapy, by Procedure Type, 2019-2026
Figure 16: North American Market for Embolotherapy, by End User, 2019-2026
Figure 17: European Market for Embolotherapy, by Product Type, 2019-2026
Figure 18: European Market for Embolotherapy, by Indication, 2019-2026
Figure 19: European Market for Embolotherapy, by Procedure Type, 2019-2026
Figure 20: European Market for Embolotherapy, by End User, 2019-2026
Figure 21: APAC Market for Embolotherapy, by Product Type, 2019-2026
Figure 22: APAC Market for Embolotherapy, by Indication, 2019-2026
Figure 23: APAC Market for Embolotherapy, by Procedure Type, 2019-2026
Figure 24: APAC Market for Embolotherapy, by End User, 2019-2026
Figure 25: APAC Market for Embolotherapy, by End User, 2019-2026
Figure 26: RoW Market for Embolotherapy, by Product Type, 2019-2026
Figure 27: RoW Market for Embolotherapy, by Procedure Type, 2019-2026
Figure 28: RoW Market for Embolotherapy, by End User, 2019-2026
Figure 29: Global Company Market Shares of Embolotherapy, 2020
Figure 30: Boston Scientific Corp.: Total Sales Share, by Business Segment, 2020
Figure 31: Boston Scientific Corp.: Total Revenue Share, by Region, 2020
Figure 32: Johnson & Johnson: Total Sales Share, by Business Segment, 2020
Figure 33: Johnson & Johnson: Total Revenue Share, by Region, 2020
Figure 34: Medtronic Plc: Total Sales Share, by Business Segment, 2020
Figure 35: Medtronic Plc: Total Revenue Share, by Region, 2020
Figure 36: Merit Medical Systems Inc.: Total Sales Share, by Business Segment, 2020
Figure 37: Merit Medical Systems Inc.: Total Revenue Share, by Region, 2020
Figure 38: Penumbra: Total Sales Share, by Business Segment, 2020
Figure 39: Penumbra: Total Revenue Share, by Region, 2020
Figure 40: Stryker Corp.: Total Sales Share, by Business Segment, 2020
Figure 41: Stryker Corp.: Total Revenue Share, by Region, 2020
Figure 42: Terumo Corp.: Total Sales Share, by Business Segment, 2019
Figure 43: Terumo Corp.: Total Revenue Share, by Region, 2019


More Publications